首页 | 本学科首页   官方微博 | 高级检索  
检索        

肺岩宁颗粒干预细胞周期G1/S检测点调控信号抗Lewis肺癌细胞增殖的研究
引用本文:郑展,王菊勇,徐振晔.肺岩宁颗粒干预细胞周期G1/S检测点调控信号抗Lewis肺癌细胞增殖的研究[J].中国中西医结合杂志,2009,29(11):1018-1022.
作者姓名:郑展  王菊勇  徐振晔
作者单位:上海中医药大学中医肿瘤研究所,上海中医药大学附属龙华医院肿瘤科,上海,200032
摘    要:目的 观察肺岩宁颗粒对Lewis肺癌小鼠肿瘤生长、肿瘤细胞周期分布,以及G1/S检测点调控信号RB-E2F1生物轴的影响。 方法 采用C57BL/6小鼠,造模并随机分为6组:模型组、顺铂组、肺岩宁煎剂组(煎剂组)、肺岩宁颗粒低剂量组(低剂量组,0.3 g)、肺岩宁颗粒中剂量组(中剂量组,0.6 g)、肺岩宁颗粒高剂量组(高剂量组,1.2 g)。造模后顺铂组1、3、5天腹腔注射顺铂0.1 mg,其他各组分别灌胃给药14天,观察各组治疗后抑瘤率、瘤重、体重,流式细胞术检测细胞周期时相分布,RT-PCR测定肿瘤组织视网膜母细胞瘤蛋白(RB)-腺病毒E2启动子结合转录因子(E2F1)的mRNA表达,Western blot检测RB、E2F1蛋白表达。 结果 各用药组瘤重低于模型组(P<0.05,P<0.01),中剂量组体重明显高于模型组和顺铂组(P<0.05,P<0.01)。流式细胞术发现中剂量组的G0/G1比例较模型组、顺铂组和煎剂组显著增多(P<0.01),癌细胞增殖指数明显降低(P<0.01,P<0.05)。RT-PCR显示中剂量组E2F1 mRNA水平明显低于模型组、顺铂组和煎剂组(P<0.01);中剂量组RB mRNA表达明显高于模型组、顺铂组和煎剂组 (P<0.01)。Western blot分析显示中剂量组较模型组和顺铂组明显抑制E2F1蛋白表达(P<0.05),并较模型组、顺铂组和煎剂组明显增加RB蛋白表达(P<0.05)。 结论 肺岩宁颗粒抑制Lewis肺癌肿瘤生长与干预细胞周期时相分布有关,能使癌细胞较多的阻滞在细胞周期G0/G1期,通过抑制E2F1,增强RB表达,从而干预细胞周期G1/S检测点信号通路中RB-E2F1生物轴实现抗肺癌增殖。

关 键 词:Lewis肺癌  肿瘤增殖  细胞周期  G1/S检测点  调控信号

Effect of Feiyanning Granule in Antagonizing Lewis Lung Cancer Cell Proliferation through Cell Cycle G1/S Checkpoint Dominating Signaling Intervention
Authors:ZHENG Zhan  WANG Ju-yong and XU Zhen-ye
Institution:Long- hua (Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai 200032)
Abstract:Objective To observe the effect of Feiyanning Granule (FYN) on tumor growth and cell cycle distribution in mice with Lewis lung cancer, as well as its influence on G1/S cell cycle checkpoint dominating signaling RB-E2F1 bio-axis. Methods Modeled C57BL/6 mice were randomly divided into 6 groups: the model group (A), the DDP treated group (B) peritoneally injected with cisplatin 0.1 mg on dl, d3 and d5 after modeling, and the 4 FYN treated groups (C-F), administered via gastrogavage with FYN Decoction, and FYN Granule in small-, median- and high- dose respectively for 14 days. The tumour inhibiting rate, tumour weight, and body weight of mice were observed after treatment; cell cycle distribution was detected by flow cytometry ( FCM), RB- E2FlmRNA expressions in tumour tissue were analyzed by RT-PCR, and their protein expressions by Western blot. Results Tumour weight in the 5 treated groups was lower than that in the model group (P 〈 0.05, P 0.01). Body weight in group E was significantly higher than that in group A and B (P 〈0.05, P〈0.01 ). FCM analysis showed the proportion of G0/G1 phase was higher in group E than in group A, B and C (P〈0.01), and cancer cell proliferation index (P1) in group E was lower than in group B ( P 〈0. 05, P 〈0. 01 ). RT-PCR showed mRNA level of E2F1 was lower, but that of RB was significantly higher in group E than those in group A, B and C respectively (P〈0.01). Western blot analysis showed the protein expression of E2F1 was lower in clrout) E and B than that in group A (P 〈0.05), while the protein expression of Rb in group E was higher than that in group A, B and C ( P 〈 0.05). Conclusion The effect of FYN in inhibiting Lewis lung cancer growth was related to its intervention on cancer cell cycle distribution which blocks most tumor cells in G0/G1 phase. Moreover, FYN can reduce MDM2 expression, enhance P53 expression to influence cell cycle G1/S checkpoint dominating signaling, so as to achieve the effect of antagonizing lung cancer cell proliferation.
Keywords:Lewis lung cancer  cancer proliferation  cell cycle  G1/S checkpoint  dominating signalingpathway
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《中国中西医结合杂志》浏览原始摘要信息
点击此处可从《中国中西医结合杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号